Patents by Inventor Ravi Prakash Reddy Nanga

Ravi Prakash Reddy Nanga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11337647
    Abstract: A magnetic resonance pulse sequence technique may acquire a water reference spectrum and two water suppressed metabolite spectra and with frequency selective inversion pulse centered at either single frequency, at multiple frequencies, or in a single acquisition. Subtraction of the inverted from non-inverted water suppressed metabolite spectrum results in single or a combination of specific metabolite peak/peaks alone with a flat baseline for easier quantification.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: May 24, 2022
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ravinder Reddy, Ravi Prakash Reddy Nanga, Hari Hariharan
  • Patent number: 10901058
    Abstract: CEST imaging technique and MR scanning are used as an MRI method for detecting levels of lactate in vivo by exploiting the exchange of —OH protons on lactate with bulk water. In accordance with this method, one first obtains a lactate CEST MRI map of a slice of the body of a patient. A contrast agent such as pyruvate, glucose or glutamine is administered and a post-administration CEST MRI map is obtained. The difference in the spatial maps indicates the level of expression of lactate in the tissue of interest.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: January 26, 2021
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ravinder Reddy, Hari Hariharan, Catherine DeBrosse, Ravi Prakash Reddy Nanga, Puneet Bagga
  • Patent number: 10791989
    Abstract: A non-invasive imaging approach using CEST and MRS may be used to monitor the cleavage of the poly-L-glutamate (PLG) backbone. The cleavage of PLG by cathespsin B can expose exchangeable —NH2 protons in the PLG that are then monitored non-invasively through CEST. The technique can provide direct information on malignant tissue and tumor aggressiveness, and can also be used to monitor treatment.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: October 6, 2020
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mohammad Haris, Anup Singh, Kejia Cai, Ravinder Reddy, Feliks Kogan, Ravi Prakash Reddy Nanga, Hari Hariharan
  • Publication number: 20170227619
    Abstract: CEST imaging technique and MR scanning are used as an MRI method for detecting levels of lactate in vivo by exploiting the exchange of —OH protons on lactate with bulk water. In accordance with this method, one first obtains a lactate CEST MRI map of a slice of the body of a patient. A contrast agent such as pyruvate, glucose or glutamine is administered and a post-administration CEST MRI map is obtained. The difference in the spatial maps indicates the level of expression of lactate in the tissue of interest.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 10, 2017
    Inventors: Ravinder Reddy, Hari Hariharan, Catherine DeBrosse, Ravi Prakash Reddy Nanga, Puneet Bagga
  • Publication number: 20160051188
    Abstract: A magnetic resonance pulse sequence technique may acquire a water reference spectrum and two water suppressed metabolite spectra and with frequency selective inversion pulse centered at either single frequency, at multiple frequencies, or in a single acquisition. Subtraction of the inverted from non-inverted water suppressed metabolite spectrum results in single or a combination of specific metabolite peak/peaks alone with a flat baseline for easier quantification.
    Type: Application
    Filed: April 4, 2014
    Publication date: February 25, 2016
    Applicant: The Trustees of The University of Pennsylvania
    Inventors: RAVINDER REDDY, Ravi PRAKASH REDDY NANGA, Hari HARIHARAN
  • Publication number: 20160041245
    Abstract: A non-invasive imaging approach using CEST and MRS may be used to monitor the cleavage of the poly-L-glutamate (PLG) backbone. The cleavage of PLG by cathespsin B can expose exchangeable —NH2 protons in the PLG that are then monitored non-invasively through CEST. The technique can provide direct information on malignant tissue and tumor aggressiveness, and can also be used to monitor treatment.
    Type: Application
    Filed: April 4, 2014
    Publication date: February 11, 2016
    Inventors: Mohammad HARIS, Anup SINGH, Kejia CAI, Ravinder REDDY, Feliks KOGAN, Ravi PRAKASH REDDY NANGA, Hari HARIHARAN
  • Patent number: 9157976
    Abstract: CEST imaging technique and MR scanning are used as an MRI method for measuring glutaminase mediated tumors. The method takes advantage of the fact that glutamine does not exhibit a significant Chemical Exchange Saturation Transfer (CEST) effect while glutamate does. In accordance with this method, one first obtains a glutamate CEST MRI map of the area of a tumor. L-glutamine (nontoxic up to several millimolar level) or glutaminase blocker is then injected and a post injection Glutamate CEST map is obtained. The difference in the spatial maps indicates the level of expression of glutaminase in the tumor.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: October 13, 2015
    Assignee: The Trustees Of The University Of Pennsylvania
    Inventors: Ravinder Reddy, Hari Hariharan, Catherine DeBrosse, Ravi Prakash Reddy Nanga
  • Publication number: 20140213887
    Abstract: CEST imaging technique and MR scanning are used as an MRI method for measuring glutaminase mediated tumors. The method takes advantage of the fact that glutamine does not exhibit a significant Chemical Exchange Saturation Transfer (CEST) effect while glutamate does. In accordance with this method, one first obtains a glutamate CEST MRI map of the area of a tumor. L-glutamine (nontoxic up to several millimolar level) or glutaminase blocker is then injected and a post injection Glutamate CEST map is obtained. The difference in the spatial maps indicates the level of expression of glutaminase in the tumor.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 31, 2014
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Ravinder Reddy, Hari Hariharan, Catherine DeBrosse, Ravi Prakash Reddy Nanga